China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Value of Multimodal Ultrasound Combined with Serological Markers for the NonInvasive Di... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A study of perfusion-guided blood pressure management in older patients undergoing lapa... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Sleep-Promoting Effects of Microcurrent Stimulation Based on Sleep EEG Mon... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Seizure-onset zone localization from intracranial EEG monitoring using brain surface Do... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploration of Anesthesia Strategies for Gastrointestinal Endoscopy in Elderly Patients... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter retrospective real-world study on prostate biopsy strategies and patholog... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Crystalline Lens Morphologic and Positional Characteristics in Eyes With White Cataract... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prophylactic Use of Intranasal Esketamine Against Cumulative Perioperative Anxiety in P... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Systematic Oral Hygiene Intervention for the Prevention and Control of Oral Mucositis D... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Lorlatinib plus Sacituzumab Tirumotecan with Peripheral ctDNA Guidance as First‑Line Th... Read More